Lorad continues record sales pace

Article

Despite recessionary pressures, Lorad counts 1994 as another record year, with revenue growthin excess of 45%. The Danbury, CT, mammography equipment manufacturerreported sales of $55 million for the fiscal year ending Dec.31, compared to $37.5 million

Despite recessionary pressures, Lorad counts 1994 as another record year, with revenue growthin excess of 45%. The Danbury, CT, mammography equipment manufacturerreported sales of $55 million for the fiscal year ending Dec.31, compared to $37.5 million in 1993, according to chief executiveHal Kirschner.

The firm's financial contribution to parent company ThermoThrexalso increased substantially, Kirschner said.

Lorad reported growth in all segments, but Kirschner attributedparticular strength to sales of the StereoGuide prone breast biopsysystem and its DSM digital spot mammography option. Unit and dollarsales increased considerably last year, he said.

"We also had nice growth in domestic mammography sales,as well as 100% increase in sales overseas of products sold byboth Lorad and our OEM partner Philips," he said.

Lorad was a key contributor to a spectacular year for ThermoThrex.Revenue generated in 1994 by the diversified imaging and opticalinstrument group increased 67% to $91 million.

Income growth was off the chart. The San Diego-based subsidiaryof Thermo Electron reported profits of $9.6 million compared to$495,000 in the previous year.

Kirschner sees strong signs of continued growth for Lorad thisyear. Sales bookings in January and February reached all-timehighs.

"That indicator, coupled with our strong backlog, willhelp us continue the compounded 40% annual growth pattern we'vemaintained in the past four years," he said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.